Overview
A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.
Background
A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.
Indication
For nutritional supplementation, also for treating dietary shortage or imbalance.
Associated Conditions
- Vitamin Deficiency
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2022/11/30 | Phase 3 | Active, not recruiting | |||
2020/07/20 | Early Phase 1 | Completed | |||
2020/06/11 | Phase 1 | Completed | |||
2018/06/11 | N/A | UNKNOWN | University Hospital, Clermont-Ferrand | ||
2018/02/09 | Phase 2 | Completed | |||
2017/03/08 | Phase 1 | Completed | Guohua An | ||
2014/03/04 | Phase 1 | Completed | John A Widness | ||
2012/04/06 | Phase 1 | Completed | National Institute on Aging (NIA) |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Shenzhen Joyuflsh Technology Co.,Ltd. | 83766-106 | TOPICAL | 0.5 g in 100 mL | 5/26/2025 | |
| Marnel Pharmaceuticals, Inc. | 0682-3001 | ORAL | 150 ug in 1 1 | 5/2/2014 | |
| BonGeo Pharmaceuticals, Inc. | 52796-174 | ORAL | 40 ug in 1 1 | 2/2/2024 | |
| Sandoz Inc | 54643-9023 | INTRAVENOUS | 20 ug in 5 mL | 10/28/2016 | |
| Sandoz Inc | 54643-9015 | INTRAVENOUS | 60 ug in 10 mL | 10/28/2016 | |
| Trivia Pharmaceuticals, LLC | 84781-012 | ORAL | 30 ug in 1 1 | 6/23/2025 | |
| Avion Pharmaceuticals, LLC | 75854-313 | ORAL | 280 ug in 1 1 | 1/7/2021 | |
| Hillestad Pharmaceuticals USA | 10542-009 | ORAL | 300 ug in 1 1 | 10/24/2019 | |
| Carilion Materials Management | 68151-1928 | ORAL | 150 ug in 1 1 | 11/11/2013 | |
| SLV PHARMACEUTICALS LLC DBA AUM PHARMACEUTICALS | 73317-8242 | ORAL | 150 ug in 1 1 | 9/25/2020 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| TAMIPOOL FOR INJECTION | SIN11849P | INJECTION, POWDER, FOR SOLUTION | 60 mcg/vial | 3/15/2002 | |
| CERNEVIT FOR INJECTION | SIN11975P | INJECTION, POWDER, FOR SOLUTION | 0.069 mg/vial | 6/5/2002 | |
| SOLUVIT N FOR INFUSION | SIN05209P | INJECTION, POWDER, FOR SOLUTION | 60 mcg/vial | 11/14/1990 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| CERNEVIT FOR INJ | N/A | N/A | N/A | 4/18/2008 | |
| BIHAKU TAB | N/A | N/A | N/A | 7/1/1994 | |
| HUAZIN INJ | N/A | N/A | N/A | 4/28/1982 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Energy Multi | 453128 | Medicine | A | 6/21/2024 | |
| Cellula-T oral powder jar | 43995 | Hong Sp & Hs | Medicine | A | 4/13/1993 |
| BLACKMORES SUPERKIDS MULTI CHEWABLES | 289492 | Medicine | A | 5/30/2017 | |
| Super B Complex tablets | 126510 | Medicine | A | 3/28/2006 | |
| MaxN-Fuze Multivitamins | 288444 | Max Health & Living Australia Pty Ltd | Medicine | A | 5/1/2017 |
| Wealthy Health Bio-Maxi B Excellent Stress Relief Formula with Herbs | 139048 | Medicine | A | 5/21/2007 | |
| Caruso's Hair Food | 130857 | Medicine | A | 8/30/2006 | |
| Berocca Performance Original effervescent tablets | 193893 | Medicine | A | 1/17/2012 | |
| Threshold Controlled B-Complex | 276600 | Medicine | A | 6/15/2016 | |
| Men's Multi | 326959 | Medicine | A | 12/2/2019 |